We are live on
!
Find out more
SC
Sessa Capital Portfolio holdings
AUM
$5.98B
1-Year Est. Return
99.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.92%
1 Year Est. Return
+99.85%
3 Year Est. Return
+146.79%
5 Year Est. Return
+201.69%
10 Year Est. Return
+788.83%
AUM
$7.06B
AUM Growth
+$4.42B
(+168%)
Cap. Flow
-$440M
Cap. Flow
% of AUM
-6.24%
Top 10 Holdings %
Top 10 Hldgs %
96.65%
Holding
39
New
1
Increased
8
Reduced
6
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$205M |
| 2 |
Garrett Motion
GTX
|
+$147M |
| 3 |
Equitable Holdings
EQH
|
+$107M |
| 4 |
Corebridge Financial
CRBG
|
+$25M |
| 5 |
First Citizens BancShares
FCNCA
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$214M |
| 2 |
GTXAP
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
|
+$148M |
| 3 |
GE HealthCare
GEHC
|
+$123M |
| 4 |
AIV
Aimco
AIV
|
+$76.4M |
| 5 |
American International
AIG
|
+$73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.83% |
| 2 | Financials | 11.81% |
| 3 | Communication Services | 6.74% |
| 4 | Consumer Staples | 3.95% |
| 5 | Consumer Discretionary | 2.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
Humana
HUM
$47.6B
| – | – |
-40,000
| Closed | -$19.4M |
|
|
JBGS
27
JBG SMITH
JBGS
$652M
| – | – |
-1,000,000
| Closed | -$15.1M |
|
28
State Street SPDR S&P Regional Banking ETF
KRE
$4.31B
| – | – |
-417,000
| Closed | -$18.3M |
|
29
Labcorp
LH
$26.3B
| – | – |
-325,920
| Closed | -$64.2M |
|
30
MacroGenics
MGNX
$257M
| – | – |
-244,864
| Closed | -$1.76M |
|
|
NML
31
Neuberger Energy Infrastructure and Income Fund Inc
NML
$603M
| – | – |
-517,789
| Closed | -$3.4M |
|
32
Nextpower Inc. Common Stock
NXT
$12.1B
| – | – |
-175,000
| Closed | -$6.35M |
|
33
Rogers Corp
ROG
$2.34B
| – | – |
-35,123
| Closed | -$5.74M |
|
|
SCHW
34
Charles Schwab
SCHW
$186B
| – | – |
-902,313
| Closed | -$47.3M |
|
35
Tandem Diabetes Care
TNDM
$1.13B
| – | – |
-121,820
| Closed | -$4.95M |
|
36
CALL
Warner Bros
WBD
$70.3B
| – | – |
-1,000,000
| Closed | -$15.1M |
|
|
GTXAP
37
DELISTED
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
| – | – |
-16,592,384
| Closed | -$148M |
|
|
PRVB
38
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| – | – |
-8,879,023
| Closed | -$214M |
|
Similar funds
DWM
DAS
AUB
FMWA
JPH
DRZID
HW
CIC
Sessa Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Sessa Capital held 39 positions worth $7.06B, up 168% from $2.64B the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Sessa Capital withdrew a net $440M in Q2 2023, closing 19 positions and reducing 6 holdings. Its most notable exit was Provention Bio, Inc. Common Stock, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, up from 15% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Sessa Capital opened a new position in EVgo worth $1.89M.
- Sessa Capital's largest Q2 2023 buy was EVgo: 472,887 shares worth $1.89M.
- Sessa Capital added most to Kellanova in Q2 2023, an estimated $205M increase.
- Sessa Capital's biggest Q2 2023 reduction was Syneos Health, Inc. Class A Common Stock, cutting an estimated $23.8M.
- Sessa Capital fully exited Provention Bio, Inc. Common Stock in Q2 2023, selling an estimated $214M.
- Sessa Capital's ten largest holdings make up 97% of its $7.06B portfolio in Q2 2023.
- Sessa Capital opened 1 new position and closed 19 in Q2 2023.
- Sessa Capital's portfolio value rose 168% quarter-over-quarter to $7.06B.
Based on Sessa Capital's 13F filing for Q2 2023, filed 14 Aug 2023.